--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the ... as well as transformative products in other disease areas including ...

Gilead Sciences ... products in other disease areas including immunology, hematology, oncology, and infectious diseases. Dr. Berger completed his medical training in Freiburg (Germany), Basel ...

Dr. Mirdamadi’s extensive education includes a Master of Science ... MD/Process MitoThrive provides a well-researched, effective option for those looking to maintain their vitality and quality ...

--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January ... as well as transformative products in other disease areas ...

Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human ...

We are delighted to welcome Kristen and Nancy to our Board of Directors,” said Tom King, Executive Chairman of Achieve’s Board of Directors. “Their wealth of knowledge and experience in strategic ...

What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

2024 was eventful in the life sciences space – and key trends are expected to continue in the new year. Below, we outline key areas to watch in 2025. In recent years, several trends have heightened ...

Dec. 30, 2024 — A new species of black, slender moray eel has chosen the road less traveled, thriving in dim and muddy river mouths, unlike most of its marine ... Six New Tree Species Named: 3 ...

Sai Life Sciences IPO listing: Sai Life Sciences shares made a strong debut on Wednesday, December 18 as they listed at ₹650 on NSE, a premium of 18.4 percent over the issue price of ₹549.